<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nguyen VP</submitter><funding>National Eye Institute</funding><funding>NEI NIH HHS</funding><funding>Research to Prevent Blindness</funding><funding>International Retinal Research Foundation</funding><funding>Department of Ophthalmology and Visual Sciences, University of Michigan</funding><pagination>13289-13306</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8984873</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(8)</volume><pubmed_abstract>Stem cell regenerative medicine therapies have emerged as promising treatments for currently incurable diseases. A remaining challenge for cell therapies is the ability to track the migration and distribution of the transplanted cells in a long-term, noninvasive manner &lt;i>in vivo&lt;/i> to assess their efficacy. This study develops a noninvasive, and high spatial resolution photoacoustic microscopy (PAM) and optical coherence tomography (OCT) imaging system for &lt;i>in vivo&lt;/i> tracking of subretinally injected progenitor human retinal pigment epithelium cells (ARPE-19) labeled with chainlike gold nanoparticle (CGNP) clusters in RPE damage. CGNP provided significant PAM, OCT, and fluorescence signals to selectively track the migration of ARPE-19 cells in living rabbit eyes for 3 months. PAM and</pubmed_abstract><journal>ACS nano</journal><pubmed_title>Long-Term, Noninvasive &lt;i>In Vivo&lt;/i> Tracking of Progenitor Cells Using Multimodality Photoacoustic, Optical Coherence Tomography, and Fluorescence Imaging.</pubmed_title><pmcid>PMC8984873</pmcid><funding_grant_id>1K08EY027458</funding_grant_id><funding_grant_id>K08 EY027458</funding_grant_id><funding_grant_id>P30 EY007003</funding_grant_id><funding_grant_id>FFSGIA16002</funding_grant_id><pubmed_authors>Zhang W</pubmed_authors><pubmed_authors>Paulus YM</pubmed_authors><pubmed_authors>Qian W</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Fan W</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Wang X</pubmed_authors><pubmed_authors>Nguyen VP</pubmed_authors><pubmed_authors>Zhu T</pubmed_authors><pubmed_authors>Henry J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-Term, Noninvasive &lt;i>In Vivo&lt;/i> Tracking of Progenitor Cells Using Multimodality Photoacoustic, Optical Coherence Tomography, and Fluorescence Imaging.</name><description>Stem cell regenerative medicine therapies have emerged as promising treatments for currently incurable diseases. A remaining challenge for cell therapies is the ability to track the migration and distribution of the transplanted cells in a long-term, noninvasive manner &lt;i>in vivo&lt;/i> to assess their efficacy. This study develops a noninvasive, and high spatial resolution photoacoustic microscopy (PAM) and optical coherence tomography (OCT) imaging system for &lt;i>in vivo&lt;/i> tracking of subretinally injected progenitor human retinal pigment epithelium cells (ARPE-19) labeled with chainlike gold nanoparticle (CGNP) clusters in RPE damage. CGNP provided significant PAM, OCT, and fluorescence signals to selectively track the migration of ARPE-19 cells in living rabbit eyes for 3 months. PAM and</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-04T09:02:37.85Z</modification><creation>2025-04-04T09:02:37.85Z</creation></dates><accession>S-EPMC8984873</accession><cross_references><pubmed>34378374</pubmed><doi>10.1021/acsnano.1c03035</doi></cross_references></HashMap>